Literature DB >> 1825338

Chloroquine-induced pruritus: its impact on chloroquine utilization in malaria control in Dar es Salaam.

K S Mnyika1, C M Kihamia.   

Abstract

To confirm reports that chloroquine-induced pruritus might have a negative impact on chloroquine utilization on malaria control in Dar es Salaam, a precoded questionnaire was administered to 300 malaria patients and the respondents were then followed up at their homes during the period of their malaria treatment. It was found that 45% of the study population had suffered from chloroquine-induced pruritus at some time in their life and 27% complained of it during the study. Chloroquine-induced pruritus was found to have a significant negative impact on chloroquine utilization on malaria control in Dar es Salaam, Tanzania (P less than 0.001). The defaulting rate attributable to chloroquine-induced pruritus was 64%. The high defaulting rate (91%) among the patients with chloroquine-induced pruritus is suspected to be among the factors that contribute to the emergence and spread of resistant malaria parasites in Dar es Salaam. However, studies are needed to confirm this point. Studies are also needed to determine if there may be familial predisposition to chloroquine-induced pruritus as hypothesized in this study.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825338

Source DB:  PubMed          Journal:  J Trop Med Hyg        ISSN: 0022-5304


  12 in total

1.  Itch: Cells, Molecules, and Circuits.

Authors:  Kush N Patel; Xinzhong Dong
Journal:  ACS Chem Neurosci       Date:  2011-01-19       Impact factor: 4.418

2.  Role of spinal bombesin-responsive neurons in nonhistaminergic itch.

Authors:  Tasuku Akiyama; Mitsutoshi Tominaga; Kenji Takamori; Mirela Iodi Carstens; E Carstens
Journal:  J Neurophysiol       Date:  2014-08-13       Impact factor: 2.714

3.  Characterization of pruriceptive trigeminothalamic tract neurons in rats.

Authors:  Hannah R Moser; Glenn J Giesler
Journal:  J Neurophysiol       Date:  2014-01-29       Impact factor: 2.714

4.  The distinct roles of two GPCRs, MrgprC11 and PAR2, in itch and hyperalgesia.

Authors:  Qin Liu; Hao-Jui Weng; Kush N Patel; Zongxiang Tang; Haihua Bai; Martin Steinhoff; Xinzhong Dong
Journal:  Sci Signal       Date:  2011-07-12       Impact factor: 8.192

5.  Glutamate in primary afferents is required for itch transmission.

Authors:  Lian Cui; Jeff Guo; Suna L Cranfill; Mayank Gautam; Janardhan Bhattarai; William Olson; Katherine Beattie; Rosemary C Challis; Qinxue Wu; Xue Song; Tobias Raabe; Viviana Gradinaru; Minghong Ma; Qin Liu; Wenqin Luo
Journal:  Neuron       Date:  2022-01-04       Impact factor: 17.173

6.  Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus.

Authors:  Qin Liu; Zongxiang Tang; Lenka Surdenikova; Seungil Kim; Kush N Patel; Andrew Kim; Fei Ru; Yun Guan; Hao-Jui Weng; Yixun Geng; Bradley J Undem; Marian Kollarik; Zhou-Feng Chen; David J Anderson; Xinzhong Dong
Journal:  Cell       Date:  2009-12-10       Impact factor: 41.582

7.  Mechanisms of itch evoked by β-alanine.

Authors:  Qin Liu; Parul Sikand; Chao Ma; Zongxiang Tang; Liang Han; Zhe Li; Shuohao Sun; Robert H LaMotte; Xinzhong Dong
Journal:  J Neurosci       Date:  2012-10-17       Impact factor: 6.167

Review 8.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

9.  Pirt, a TRPV1 modulator, is required for histamine-dependent and -independent itch.

Authors:  Kush N Patel; Qin Liu; Sonya Meeker; Bradley J Undem; Xinzhong Dong
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

10.  The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum.

Authors:  Sodiomon B Sirima; Alfred B Tiono; Adama Gansané; Amidou Diarra; Amidou Ouédraogo; Amadou T Konaté; Jean René Kiechel; Caroline C Morgan; Piero L Olliaro; Walter R J Taylor
Journal:  Malar J       Date:  2009-03-16       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.